Hyloris Pharmaceuticals SA(GB:0AB6)
€3.97-0.24 (-5.70%)
GB:0AB6
Hyloris Pharmaceuticals SA financials statements
€3.97
At close:-0.24 (-5.70%)
Hyloris Pharmaceuticals SA (0AB6) Income Statement
1 Followers
Hyloris Pharmaceuticals SA Income Statement
Last quarter (Q4 2025), Hyloris Pharmaceuticals SA's total revenue was €2.30M, a decrease of 14.85% from the same quarter last year. In Q4, Hyloris Pharmaceuticals SA's net income was €-1.39M. See Hyloris Pharmaceuticals SA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 7.21M | € 10.04M | € 2.09M | € 2.95M | € 3.10M | |
| € 5.91M | € 9.81M | € 1.99M | € 2.86M | € 2.99M | |
| € 15.24M | € 16.95M | € 17.99M | € 13.37M | € 13.34M | |
| Depreciation and Amortization | € 720.00K | € 1.23M | € 348.00K | € 196.00K | € 114.00K |
| € -8.62M | € -4.85M | € -14.98M | € -11.43M | € -10.78M | |
| € -9.34M | € -7.13M | € -15.99M | € -11.64M | € -4.94M | |
| € 2.63M | € 788.00K | € 613.00K | € -263.00K | € -741.00K | |
| € -6.71M | € -6.34M | € -15.38M | € -11.90M | € -11.28M | |
| € -6.33M | € -6.34M | € -15.38M | € -11.91M | € -11.58M | |
| Per Share Metrics | |||||
| Basic EPS | € -0.23 | € -0.22 | € -0.55 | € -0.44 | € -0.45 |
| Diluted EPS | € -0.23 | € -0.22 | € -0.55 | € -0.44 | € -0.45 |
| Weighted Average Shares Outstanding | 27.54M | 29.04M | 28.00M | 27.20M | 25.83M |
| Weighted Average Shares Outstanding (Diluted) | 27.54M | 29.04M | 28.00M | 27.20M | 25.83M |
Currency in EUR
